Format

Send to

Choose Destination
Lancet Oncol. 2014 Feb;15(2):124-5. doi: 10.1016/S1470-2045(14)70010-5.

Angiogenesis inhibition and lung-cancer therapy.

Author information

1
Sheba Medical Center, Institute of Pulmonology, Tel Hashomer, Ramat Gan, Israel.
2
Institute of Oncology, Tel Hashomer, Ramat Gan, Israel.
3
Yale Cancer Center, Section of Medical Oncology, New Haven, CT 06520, USA. Electronic address: roy.herbst@yale.edu.
PMID:
24480554
DOI:
10.1016/S1470-2045(14)70010-5
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center